Blocking a single protein with an experimental drug prevented and treated both type 2 diabetes and atherosclerosis in laboratory mice that had been fed unhealthy diets and were genetically predisposed to these common killers, according to an article published online at Nature on June 6, 2007.
A study of more than 33,000 type 2 diabetes patients in a real-world setting was published today. This study shows that the incidence of hospitaliations for heart attack, and/or for a surgery known as coronary revascularization for patients on Avandia is the same as for other diabetes treatments.
The synthetic form of a hormone previously found to produce a feeling of fullness when eating and reduce body weight, also may help curb binge eating and the desire to eat high-fat foods and sweets.
Abbott announced that it received European CE Mark (Conformit? Europ?ene) approval for the FreeStyle Navigator? Continuous Glucose Monitoring System for people with diabetes.
A study of 17 middle school students suggests that physical fitness gains made by obese children who participated in a lifestyle-focused physical education class during the school year were lost after the three-month summer break, according to a report in the June issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Normally sedentary breast cancer survivors who completed an exercise program reduced the levels of insulin in their blood, revealing a likely link between physical activity and better outcomes, researchers from Dana-Farber Cancer Institute in Boston reported at the annual meeting of the American Society of Clinical Oncology in Chicago.
Januvia (scientific name sitagliptin), a new drug designed to improve blood sugar control in patients with type 2 diabetes, should not be used because the drug?s long-term safety is still unknown, Public Citizen writes in a new June posting on its WorstPills.org Web site.
University of Florida researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in people at risk for the disease.
Researchers in endocrinology and obstetrics and gynecology at Cedars-Sinai Medical Center will make several presentations at the upcoming annual meetings of two medical organizations ? the Androgen Excess Society (June 1, 2007) and the Endocrine Society (June 2-5, 2007).
Researchers have shown that key chemicals that carry cholesterol and fats in the blood accumulate in people with type 2 diabetes, which may help improve treatment of this disease.